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Hematopoietic stem cells and their progenitors
exhibit multilineage patterns of gene expres-
sion. Molecular mechanisms underlying the
generation and refinement of these patterns
during cell fate determination remain unex-
plored because of the absence of suitable ex-
perimental systems.UsingPU.1/progenitors,
wedemonstrate that at subthreshold levels, this
Ets transcription factor regulates a mixed pat-
tern (macrophage/neutrophil) of gene expres-
sion within individual myeloid progenitors. In-
creased PU.1 levels refine the pattern and
promote macrophage differentiation by modu-
lating a novel regulatory circuit comprised of
counter antagonistic repressors, Egr-1,2/Nab-
2 and Gfi-1. Egr-1 and Egr-2 function redun-
dantly to activate macrophage genes and to re-
press the neutrophil program. These results are
used to assemble and mathematically model
a gene regulatory network that exhibits both
graded and bistable behaviors and accounts
for the onset and resolution of mixed lineage
patterns during cell fate determination.
INTRODUCTION
Hematopoietic multipotential progenitors exhibit low
levels of multilineage gene expression patterns (Hu et al.,
1997; Miyamoto et al., 2002). This phenomenon has been
termed transcriptional priming and it appears to reflect,
at amolecular level, the developmental potency of a multi-
lineage progenitor. These observations suggest that he-
matopoietic cell fate specification depends on inductionas well as repression of subsets of lineage-specific genes.
Regulatory mechanisms that initiate and resolve mixed
lineage gene expression patterns during cell fate specifi-
cation remain unexplored because of a lack of suitable
experimentally manipulable cellular systems.
Antagonistic interplay between primary lineage deter-
mining factors has been proposed as a molecular mecha-
nism for initiating and resolving mixed lineage states
(Orkin, 2000). This widely accepted model is based on
studies which have demonstrated that transcription fac-
tors such as GATA-1 and PU.1 physically interact and
can functionally antagonize one another in transactivation
and differentiation assays (Rekhtman et al., 1999; Zhang
et al., 1999). Although this is an attractive regulatorymodel,
its key features remain to be rigorously tested in a suitable
experimental system that dynamically primes and resolves
alternate lineage expression patterns during cell fate de-
termination. Furthermore, the model does not account
for specification of cell fates that involve cooperative rather
than antagonistic interplay between primary lineage-
determining transcription factors; although GATA-2 and
PU.1 have also been shown to mutually antagonize one
another, the development of mast cell precursors requires
their cooperative interplay (Walsh et al., 2002).
Macrophage and neutrophil cell fate specification re-
quire the transcription factors PU.1 and C/EBPa, respec-
tively (Scott et al., 1994; Zhang et al., 1997). The relative
levels of PU.1 and C/EBPa in granulocytic-macrophage
progenitors have been suggested to regulatemacrophage
versus neutrophil cell fate choice (Dahl et al., 2003), al-
though the underlying molecular mechanism remains ob-
scure. Paradoxically, both transcription factors are highly
expressed in macrophages and neutrophils and synergis-
tically regulate transcription of genes that are active in one
or the other cell type (Smith et al., 1996; Zhang et al.,
1996). This regulatory feature is not taken into consider-
ation by the aforementioned regulatory model.Cell 126, 755–766, August 25, 2006 ª2006 Elsevier Inc. 755
We establish a cellular system to analyze mixed lineage
transcriptional priming and its resolution in the context of
macrophage versus neutrophil cell fate determination. The
analysis uncovers a novel regulatory circuit comprised of
counter-acting (mutual) repressors. Mathematical model-
ing of the assembled gene regulatory network shows that
such a network architecture can exhibit both graded and
bistable (switch-like) behaviors. The model accounts for
both the onset and resolution of mixed lineage patterns
during cell fate determination. In particular, the model
shows how upregulation of a common pair of primary
lineage determinants can contribute to specification and
commitment from a cell state in which the potential for
two distinct fates coexists.
RESULTS
Subthreshold Levels of PU.1 Activate a Mixed
Lineage Pattern of Gene Expression
PU.1/ myeloid progenitors can be expanded in culture
using the cytokine IL-3 and established as cell lines (Walsh
et al., 2002). These cells can be induced to differentiate
into macrophages or neutrophils by re-expression of
PU.1. Cell fate specification in this system is dictated by
the relative levels of PU.1 and C/EBPa at the onset of dif-
ferentiation (Dahl et al., 2003;Walsh et al., 2002). The PU.1
gene is expressed at low levels in common myeloid pro-
genitors (CMP) and its expression is induced in vivo and
in vitro as these cells differentiate into macrophages and
neutrophils (Nutt et al., 2005; see Figure S1 in the Supple-
mental Data). To examine the consequences of differing
levels of PU.1 on the differentiation fate of PU.1/ mye-
loid progenitors, we made use of mutant clones express-
ing varied physiological levels of a conditionally active
PU.1 protein fused to the ligand binding domain of the es-
trogen receptor (PUER). The PUERhi cells express approx-
imately 5-fold higher levels of the PUER transcript (Fig-
ure S1) and the fusion protein (Figure 1A) compared with
PUERlo counterparts. The levels of PU.1 RNA in PUERlo
and PUERhi cells are physiologically appropriate as they
are comparable to those observed in CMPs and macro-
phages, respectively (Figure S1).
In the absence of 4-hydroxy-tamoxifen (OHT), both
PUERlo and PUERhi cells retain myeloid progenitor mor-
phology (Figure 1A) andare c-kithiGr-1loF4/80 (FigureS2).
UponOHTaddition, thePUERhi cells undergo rapid growth
arrest and differentiate within 4 to 7 days into adherent
c-kitCD11bhiF4/80+macrophages (Figure 1A, Figure S2).
In contrast, the PUERlo cells do not undergo discernable
morphological differentiationwithOHTaddition (Figure 1A,
Figure S2). PUERlo and PUERhi cells were analyzed for the
expression of macrophage- or neutrophil-specific genes
(Figure 1B). Strikingly, the induction of PU.1 activity in
PUERlo cells appears to activate a mixed (macrophage/
neutrophil) pattern of gene expression within 24 hr. This
pattern is sustained over the course of 4 to 7 days and is
not accompanied by overt differentiation (Figures 1A and
1B). Induction of PU.1 activity in PUERhi cells also seem-756 Cell 126, 755–766, August 25, 2006 ª2006 Elsevier Inc.ingly activates a mixed lineage pattern of gene expression
within 24 hr (Figure 1B). However, this pattern, with the ex-
ception of G-CSFR, is resolved into a macrophage-spe-
cific subset. As noted above, the PUERhi cells undergo
overt differentiation into macrophages within 4 to 7 days.
To test if PU.1 activates a mixed lineage pattern of gene
expression within individual cells, we treated PUERhi cells
for 24 hr with OHT and performed single-cell multiplex
Figure 1. PU.1 Transiently Activates a Mixed Lineage Pattern
of Gene Expression in Myeloid Progenitors
(A) Immunoblot analysis of IL-3 cultured PU.1/ cell clones express-
ing different levels of a PU.1 fusion protein containing the ligand bind-
ing domain of the estrogen receptor (upper panel). Protein levels were
normalized using a cross-reactive band. PUER activity was induced by
the addition of 100 nM OHT. Cellular morphology was examined by
Wright staining after 7 days (lower panel).
(B) Myeloid gene expression patterns in PUERlo and PUERhi cells in-
duced with OHT for 1 and 4 days. Transcripts for the indicated myeloid
genes were analyzed by RT-PCR after normalization with hprt. Total
RNA from purified macrophages (Mac.) and neutrophils (Neut.) were
used as controls.
(C) Single-cell multiplex RT-PCR analysis of OHT treated (1 day)
PUERhi cells.
Figure 2. High Levels of PU.1 Induce Egr-2 and Nab-2, which Repress Neutrophil Genes
(A) Expression of PU.1-regulated transcription factors in PUERlo and PUERhi cells. PU.1 activity was induced with OHT for the indicated times.
(B) Immunoblot analysis of PUERhi clones stably expressing either a shEgr-2 RNA or shNab-2 RNA (upper panel). The ability of shEgr-2 and shNab-2
cells to differentiate into macrophages was analyzed by Wright staining (lower panel).
(C) Expression of various macrophage or neutrophil transcripts was analyzed by RT-PCR.
(D) Genome-wide expression analysis using Affymetrix gene chips. Venn diagrams of macrophage (left panel) and neutrophil (right panel) genes
expressed in PUERhi, shEgr-2, or shNab-2 cells after induction of PU.1 activity (OHT, 4 days). Of the 142 macrophage genes induced by PU.1,
the expression of 40 is impaired by knockdown of Egr-2, and the expression of 25 is impaired by reduction of Nab-2 levels. Seventy neutrophil-
specific genes are mis-expressed in shEgr-2 cells. Eighteen of these genes are also mis-expressed in shNab-2 cells.RT-PCR (Figure 1C). Of 21 single cells that were analyzed,
all coexpressed at least one macrophage- and neutrophil-
specific gene. These results reveal that the PUER cells
represent an experimentally manipulable model system
for analyzing regulatory mechanisms that underlie tran-
scriptional priming and resolution during cell fate determi-
nation. Furthermore, the experiments demonstrate that
subthreshold levels of PU.1 activate a mixed lineage pat-
tern of gene expression within individual myeloid progen-
itors. An increase in PU.1 activity beyond the threshold
induces resolution of the mixed lineage pattern and is
accompanied by overt differentiation into macrophages.
PU.1 Induces Egr-2 and Nab-2, which Repress
Neutrophil Genes duringMacrophage Differentiation
The repression of neutrophil genes during macrophage
differentiation could be directly mediated by higher levels
of PU.1 or indirectly mediated via the induction of a nega-
tive regulator(s). We explored these possibilities by per-
forming genome-wide expression analysis. Among the
large set of genes whose expression was induced by
PU.1, ten encoded regulatory factors (data not shown).The expression of five of these regulatory genes (Id2,
Egr-2, Nab-2, Miz1, and NCoA3) was strongly induced in
PUERhi, but not PUERlo, cells (Figure 2A).
Egr-2 (Krox-20) and Nab-2 were of interest since the re-
lated zinc finger family transcription factor Egr-1 (Krox-24)
has been implicated in regulating macrophage differentia-
tion (Nguyen et al., 1993). Furthermore, Egr-1 and Egr-2
interact with the corepressor Nab-2, which can inhibit
the ability of Egr proteins to activate transcription (Svaren
et al., 1996). These results suggested that PU.1-induced
Egr/Nab complexes could function in the repression of
neutrophil-specific genes. To test this, we employed a
shRNA-based approach. PUERhi cells expressing shRNA
directed against Egr-2 (shEgr-2) showed a reduction (ap-
proximately 5-fold) in the accumulation of Egr-2 protein
upon activation of PUER (Figure 2B). We note that PUERhi
cells express Egr-1 and that its expression is downregu-
lated by inducing high PU.1 activity. Importantly, the
Egr-2 shRNA did not perturb the levels of Egr-1 protein.
Induction of PU.1 activity in the shEgr-2 cells resulted in
a strikingmorphological alteration (Figure 2B). The cells in-
creased in size with an extensive cytoplasm resemblingCell 126, 755–766, August 25, 2006 ª2006 Elsevier Inc. 757
that of a macrophage but contained segmented nuclei
with numerous lobes, a feature characteristic of neutro-
phils. Additionally, these cells did not adhere and failed
to express the F4/80 antigen (Figure S2). The shEgr-2 cells
not only induced but also sustained a mixed pattern of
gene expression, with high levels of certain macrophage
(mmp12) and neutrophil (IL-1R (II), lactoferrin, proteinase
3) RNAs (Figure 2C). These results demonstrate that
PU.1 initially activates a mixed lineage pattern of gene
expression in myeloid progenitors, then utilizes Egr-2 to
resolve this pattern into a macrophage-specific output.
To determine if Nab-2 functions in concert with Egr-2,
we stably expressed a shNab-2 construct. This construct
resulted in a 3-fold reduction of the basal and PU.1-in-
duced levels of the Nab-2 protein (Figure 2B). Attenuation
of Nab-2 levels did not appreciably affect the PU.1-depen-
dent morphological differentiation (Figure 2B). However,
the knockdown of Nab-2 protein resulted in both amarked
reduction of F4/80+ cells (Figure S2) and, importantly,
a failure to downregulate the neutrophil genes IL-1R (II)
and proteinase 3 (Figure 2C).
To examine the subsets of macrophage and neutro-
phil genes that are coregulated by Egr-2 and Nab-2, we
performed genome-wide expression analysis with the
shEgr-2 and shNab-2 cells. The induction of PU.1 in the
PUERhi cells resulted in the expression of 142 macro-
phage-specific genes (Figure 2D). Expression of 22 of
these genes was found to be dependent on both Egr-2
and Nab-2 (see Table S1 in the Supplemental Data). Con-
versely, attenuationof Egr-2 resulted in themis-expression
of 70 neutrophil genes, 18 of which were also improperly
expressed as a consequence of reduction of Nab-2 (Fig-
ure 2D, Table S2). The finding that Egr-2 mediates repres-
sion of a larger set of neutrophil genes than Nab-2 may be
due to the fact that Egr-2 is capable of interacting with a
related corepressor, Nab-1 (Russo et al., 1995). Neverthe-
less, our results demonstrate that Egr-2 and Nab-2 func-
tion in concert to repress a subset of 18 neutrophil-specific
genes.
We note that both Egr-2 and Nab-2 reinforce macro-
phage gene activity while antagonizing neutrophil-specific
gene expression. Egr-2 can function as a positive regula-
tor of transcription and therefore likely upregulates the
expression of a large subset of macrophage genes (Fig-
ure 2D). The molecular function of Nab-2 in promoting
macrophage differentiation is analyzed below.
Egr-2/Nab-2 and Gfi-1 Represent Counter
Antagonistic Repressors
The phenotypes of the shEgr-2 and shNab-2 cells paral-
leled those of myeloid cells lacking the zinc finger tran-
scription factor, Gfi-1. In Gfi-1/ mice, neutrophil devel-
opment is impaired and the mutant granulocytic cells
mis-express the macrophage genes, c-fms and Mac-3
(Hock et al., 2003). Collectively, these analyses led us to
consider that Egr-1,2/Nab-2 and Gfi-1 represent lineage-
specific counter-acting repressors. Consistent with this
possibility, Egr-1,2/Nab-2 andGfi-1 exhibited a reciprocal758 Cell 126, 755–766, August 25, 2006 ª2006 Elsevier Inc.pattern of expression in macrophages and neutrophils
(Figure S3). We next analyzed the dynamics of Egr-2/
Nab-2 andGfi-1 expression usingPUERhi cells, under con-
ditions that favor the generation of macrophages (IL-3) or
neutrophils (G-CSF) (Dahl et al., 2003). Macrophage differ-
entiation was accompanied by the induction of Egr-2 and
Nab-2 and the concomitant downregulation of Gfi-1
(Figure 3A). Conversely, differentiation of PUERhi cells
into neutrophils resulted in sustained expression of Gfi-1
and a failure to significantly upregulate Egr-2 or Nab-2 in
spite of induction of high PU.1 activity.
Impairing Egr-2 or Nab-2 induction resulted in sustained
expression of Gfi-1, demonstrating that Egr-2 and Nab-2
negatively regulate Gfi-1 expression (Figure 3B). We sug-
gest that the macrophage differentiation defect observed
in the shNab-2 cells (i.e., the failure to induce 22 macro-
phage genes, Figure 2D) is due to sustained expression
of Gfi-1, which likely represses these genes. Interestingly,
loss of Egr-2 did not affect the induction ofNab-2 and vice
versa, suggesting that both Egr-2 and Nab-2 are indepen-
dently regulated by PU.1 during macrophage differentia-
tion (Figure 3B).
Based on the above analysis, we predicted that Egr-1,2/
Nab-2 should bind the Gfi-1 gene to directly mediate its
repression. By DNA sequence analysis, we identified sev-
eral putative Egr binding sites in the promoter region of
the Gfi-1 gene. One of these sites, positioned 176 bp up-
stream of the transcription start site, is bound with high
affinity by Egr-2 (Figure S4) as well as Egr-1 (data not
shown). It has not been possible to detect the assembly
of Egr-1,2/Nab cocomplexes on DNA by gel electrophore-
sis (Svaren et al., 1996). To determine if Egr-2 and Nab-2
associate with theGfi-1 promoter, we carried out chroma-
tin cross-linking and immunoprecipitation assays. Induc-
tion of Egr-2 and Nab-2 by PU.1 resulted in their cross-
linking to the Gfi-1 promoter region containing the Egr
binding site (Figure 3B). Importantly, the Gfi-1 promoter
was repressed via the Egr site by coexpression of Egr-2
and Nab-2 (Figure 3C). Thus, Egr-2 and Nab-2 directly
repress the Gfi-1 gene.
To test if Gfi-1 can counter antagonize the expression
of Egr-1,2/Nab-2, we utilized PUERhi cells expressing
elevated levels of Gfi-1 (Figure 3B, right panel). Sustained
expression of Gfi-1 inhibits PU.1-induced macrophage
differentiation (R. Dahl, personal communication and
data not shown). Importantly, overexpression of Gfi-1 in
these cells resulted in the attenuation of both Egr-1 and
Egr-2 expression, but not Nab-2. To determine if Gfi-1 re-
pression of Egr-1 and Egr-2 can occur in the absence of
PU.1 and other myeloid regulatory factors, we expressed
Gfi-1 in NIH3T3 fibroblasts. Egr-1,2/Nab-2 are induced in
fibroblasts upon serum starvation and restimulation (Sva-
ren et al., 1996). Gfi-1 inhibited the growth factor-induced
expression of both Egr-1 and Egr-2 (Figure 3B, right
panel). As was the case with PUERhi cells, Nab-2 expres-
sion was not affected by Gfi-1. The Egr-2 promoter region
(650 to +150) contains multiple putative Gfi-1 binding
sites (data not shown). Importantly, Gfi-1 could be shown
Figure 3. Egr-2/Nab-2 and Gfi-1 Repre-
sent Counter Antagonistic Repressors
(A) Expression of Egr-2, Nab-2, and Gfi-1 in
PUERhi cells after differentiation under condi-
tions that favor generation of macrophages
(IL-3) or neutrophils (G-CSF) (left panel). Ex-
pression of Egr-2, Nab-2, and Gfi-1 in PUERhi
cells upon attenuation of Egr-2 or Nab-2 (right
panel).
(B) ChIP analysis of Egr-2 and Nab-2 binding to
Gfi-1 promoter in OHT-treated PUERhi cells
(left panel). Amylase gene primers were used
as a control. RT-PCR analysis (1:5 cDNA dilu-
tion) of Egr-1, Egr-2, Nab-2, and Gfi-1 tran-
scripts in the indicated cells (right panel).
PUERhi-Gfi-1 and NIH3T3-Gfi-1 cells were
generated by retroviral transfection using a
Gfi-1 vector. PUER cells were induced with
OHT for 48 hr before RNA isolation. NIH3T3
cells were serum starved overnight and then
stimulated with 20% FCS for 1.5 hr before
RNA isolation.
(C) NIH3T3 cells were transiently transfected
with luciferase reporter plasmids containing
the Gfi-1 promoter (left panel, shaded bars) or
the Egr-2 promoter (right panel). Open bars in
left panel represent Gfi-1 promoter with muta-
tion in the Egr binding site. Promoter activity
was measured in response to levels of indi-
cated expression plasmids. Gfi-1 (P2A) is a
repression-defective mutant protein. Data is
from three independent experiments. Error
bars represent mean ± SEM.to repress the Egr-2 promoter (Figure 3C, right panel). Re-
pression by Gfi-1 required a functional SNAG domain as it
was not observed with the P2A mutant (Grimes et al.,
1996). Although the Gfi-1 binding site(s) required for Egr-
2 repression remain(s) to be delineated, our results estab-
lish that Gfi-1 can counter-repress the Egr-1 and Egr-2
genes in two different cellular contexts.
Functional Redundancy of Egr-1 and Egr-2
in Macrophage Differentiation
Egr-2/ mice exhibit perinatal lethality (Swiatek and
Gridley, 1993), but the development of macrophages in
Egr-2/ embryos has not been examined. We analyzed
the generation of myeloid cells in the fetal liver of E14.5
embryos. Loss of Egr-2 did not impair the production
of CD11b+Gr-1+ or CD11b+Gr-1 myeloid cells (data not
shown). Furthermore, Egr-2/ Lin hematopoietic pro-
genitors could be induced to differentiate into macro-
phages by culturing in M-CSF (Figure 4A).
Sincemacrophages express Egr-1, which is also not es-
sential formacrophage differentiation (Lee et al., 1996), we
reasoned that the two regulators may functionally substi-
tute for one another. Egr-2/macrophages express wild-
type levels of Egr-1, but not detectable levels of Egr-3 and
Egr-4 (Figure 4A). Furthermore, in the PU.1/ progeni-
tors, induction of PUER results in the expression of Egr-
2 and downregulation of Egr-1 (Figure 4A), thereby likely
accounting for our ability to reveal a nonredundant func-tion for Egr-2 in macrophage differentiation in these cells.
We directly tested the redundant functions of Egr-1,2 by
using the PU.1/ cell system. Initially, we complemented
shEgr-2 cells by expressing human Egr-2 (Figure 4B). This
resulted in the restoration ofPU.1-dependentmacrophage
differentiation comparable to that of control cells based
onmorphology, F4/80expression, and thedownregulation
of neutrophil genes. Importantly, increased expression of
murine Egr-1 in shEgr-2 cells also complemented the
mutant phenotype (Figure 3B). We note that neither Egr-1
nor Egr-2 promoted macrophage differentiation in the
absence of PU.1 induction (data not shown). Thus, Egr-1
and Egr-2 function redundantly in promoting macrophage
differentiation and repressing neutrophil genes.
To test the redundant role of Egr-1,2 in primary hemato-
poietic progenitors, we employed a dominant-negative
Egr protein. This protein (dEgr-2) represents the zinc finger
DNA binding domain (amino acids 330–470) of murine
Egr-2 and lacks both trans-activation and Nab interaction
domains. We generated PUERhi cells stably expressing
the dEgr-2 construct. Induction of PU.1 activity in these
cells resulted in a significant loss of F4/80+ cells, and
importantly, mis-expression of Gfi-1 (Figure 4C). These
phenotypes paralleled those of the shEgr-2 cells, thereby
validating the utility of the dEgr-2 protein. Fetal liver Lin
hematopoietic progenitors from Egr-1/ mice can differ-
entiate into macrophages as a result of Egr-2 expression.
Expression of dEgr-2 in these progenitors impaired theirCell 126, 755–766, August 25, 2006 ª2006 Elsevier Inc. 759
Figure 4. Functional Redundancy of
Egr-1 and Egr-2 in Macrophage
Differentiation
(A) Fetal liver (FL) hematopoietic Lin progeni-
tors (E14.5) were isolated from Egr-2+/+ and
Egr-2/ embryos and cultured for 4 days in
the presence of M-CSF. Macrophage differen-
tiation was analyzed by F4/80 expression and
Wright staining (left panel). RT-PCR analysis
of the Egr family members in macrophages
derived from M-CSF-cultured Lin progenitors
(1:5 cDNA dilution) and PUERhi cells induced
with OHT for 1 and 4 days (right panel). Total
RNA from mouse embryonic brain was used
as control.
(B) shEgr-2 cells were complemented with mu-
rine Egr-1 or human Egr-2 vectors. Mig-R1 is
the control vector. Macrophage differentiation
was examined after 7 days by F4/80 expres-
sion and Wright staining (left panel). RT-PCR
analysis of myeloid transcripts in the indicated
cells after PU.1-dependent differentiation (right
panel).
(C) PUERhi cells were stably transduced with
dominant Egr-2 mutant (Mig-dEgr-2) or control
Mig-R1 vectors. Macrophage differentiation
was examined after 24 hr by F4/80 expression
(upper panel). RT-PCR analysis (1:5 cDNA dilu-
tion) of Gfi-1 transcripts in the indicated cells
after PU.1-dependent differentiation (lower
panel).
(D) FL Lin progenitors (E14.5) were isolated
from Egr-1/ mice and infected with Mig-
dEgr-2 or Mig-R1 vectors. Cells were cultured
for 3 days in presence of M-CSF. Myeloid
and macrophage differentiation were analyzed
by CD11b and F4/80 expression, respectively.M-CSF-dependent differentiation into CD11b+F4/80+
macrophages (Figure 4D). These results strongly suggest
that Egr-1 and Egr-2 function redundantly to regulate the
differentiation of primary hematopoietic progenitors into
macrophages.
Egr-1/Egr-2+/ Hematopoietic Progenitors Are
Defective in Undergoing M-CSF-Dependent
Macrophage Differentiation
Loss of Egr-1 and Egr-2 results in early embryonic lethality
(Grose et al., 2002). Therefore, to genetically test the re-
dundant functions of Egr-1 and Egr-2 in regulating macro-
phage development, we made use of Egr-1/Egr-2+/
compound mutant mice. These mutant mice appeared
healthy yet displayed severe growth retardationwhen com-
pared to their wild-type, Egr-1/, or Egr-2+/ littermates
(Figure 5A, data not shown). This size difference corre-
lated with a decrease (control 21.41 ± 2.82 g; Egr-1/
Egr-2+/ 15.08 ± 2.14 g; n = 5) in total body weight. There
were no notable abnormalities in the hematopoietic sys-
tem in 5-week-old compound mutant mice in relation to
their Egr-1/ counterparts as determined by peripheral
blood and bone marrow differentials (data not shown).760 Cell 126, 755–766, August 25, 2006 ª2006 Elsevier Inc.We analyzed hematopoietic progenitors from these
mice for their ability to undergo M-CSF-dependent differ-
entiation. The compound mutant progenitors gave rise
to fewer CFU-M colonies in methylcellulose assays, and
the majority of these colonies were smaller in size than
those of their Egr-1/ control counterparts (Figure 5B).
In contrast, macrophage differentiation in response to
GM-CSF was unimpaired. When plated in liquid culture
in M-CSF, the Egr-1/Egr-2+/ progenitors gave rise to
substantially fewer (6-fold) F4/80+ macrophages (Fig-
ure 5C). Importantly, the CD11b+Gr-1-F4/80 macro-
phage precursors generated from the compound mutant
progenitors expressed higher levels of Gfi-1 (3-fold) and
lower levels of PU.1 (3-fold) transcripts (Figure 5D).
Thus, Egr-1/Egr-2+/ hematopoietic progenitors are
defective in undergoing M-CSF-dependent macrophage
differentiation and fail to properly repress the Gfi-1 gene.
In vivo, homeostatic mechanisms, e.g. GM-CSF signaling,
may enable restoration of the macrophage compartment.
Nevertheless, these results provide genetic support for
the redundant roles of Egr-1 and Egr-2 in promoting
macrophage differentiation and repressing the Gfi-1
gene.
Figure 5. Egr-1/Egr-2+/Hematopoietic Progenitors Are Defective in UndergoingM-CSF-DependentMacrophage Development
(A) 5-week-old Egr-1/ and Egr-1/Egr-2+/ littermates.
(B) Bone marrow (BM) hematopoietic Lin progenitors were isolated from Egr-1/ and Egr-1/Egr-2+/ mice and cultured in methylcellulose in
GM-CSF or M-CSF. Colony numbers were scored after 9 days. Phase contrast images of representative CFU-M colonies (right panel). Data is
from two independent experiments. Error bars represent mean ± SEM.
(C) BM Lin progenitors were isolated from Egr-1/ and Egr-1/Egr-2+/mice and cultured for 3 days in M-CSF. Myeloid and macrophage differ-
entiation were analyzed by Gr-1/CD11b and F4/80 expression, respectively.
(D) Macrophage precursors (CD11b+Gr-1F4/80) were FACS purified from 3 dayM-CSF-cultured progenitors (Figure 5C). PU.1, C/EBPa, Gfi-1, and
Egr-2 transcripts were quantitated by Q-PCR.Cross-Antagonism Yields Both Graded
and Bistable Behaviors
To analyze how the cross-antagonism between Egr-1,2/
Nab-2 and Gfi-1 initiates and resolves a mixed lineage
pattern of gene expression, we assembled a minimal
regulatory network for the macrophage-neutrophil devel-
opmental program based on our results and earlier find-
ings (Dahl et al., 2003; Hock et al., 2003; Smith et al.,
1996; Zhang et al., 1996, 1997). As shown in Figure 6A,
there are two primary cell fate determinants, PU.1 and
C/EBPa. PU.1 upregulates the secondary cell fate deter-
minants Egr-2 and Nab-2 (Figure 2A). We note that Egr-1
is also induced during macrophage differentiation (Fig-
ure S3A). Egr-1 and Egr-2 are treated as a single species
(denoted Egr) in the model due to the redundancy demon-
strated above (Figures 4 and 5). We propose that C/EBPa
regulates the secondary determinant, Gfi-1, based on the
observation that pretreatment of PUERhi cells with G-CSF
results in increased expression of C/EBPa (Dahl et al.,
2003) and Gfi-1 (Figure 3A). The primary and secondary
determinants together regulate the expression of many
downstreammacrophage and neutrophil genes. In partic-
ular, both PU.1 and C/EBPa regulate each of these genessynergistically in themodel (Supplemental Data). Negative
feedback from Gfi-1 to PU.1 was included to account
for the increased expression of PU.1 inGfi-1/ bonemar-
row (Hock et al., 2003) and the downregulation of PU.1 ac-
companied by increased expression of Gfi-1 in Egr-1/
Egr-2+/ macrophage precursors (Figure 5D). The ge-
nome-wide analysis (Figure 2D) suggests some macro-
phage and neutrophil genes are regulated autonomously
of this circuit (Figure 6A), but there are insufficient data
to include them in the model at present.
This network can be represented mathematically by a
set of differential equations that are integrated forward in
time (t) numerically (see Experimental Procedures and
the Supplemental Data). Combinations of expression
levels that do not change in time are called ‘‘fixed points.’’
Stable fixed points are robust to perturbations. We show
below that they correspond to the mixed lineage, macro-
phage, or neutrophil developmental states. Unstable fixed
points are not readily observable in experiments but are
important because they define the boundaries (in expres-
sion levels) between developmental states.
Consistent with the behavior observed for PUERlo cells
(Figure 1), a mixed lineage pattern of gene expression isCell 126, 755–766, August 25, 2006 ª2006 Elsevier Inc. 761
Figure 6. Mathematical Model of a Gene Regulatory Network
Underlying Macrophage and Neutrophil Cell Fates
(A) The network depicts primary (PU.1 and C/EBPa) and secondary
(Egr/Nab and Gfi-1) cell fate determinants and macrophage (Mac) or
neutrophil (Neut) target genes. Arrows represent positive regulation
and barred lines represent repression. In the model, PU.1 and
C/EBPa are constitutively synthesized (*). Boxes represent synergistic
activation of transcription. For simplicity, Egr-1 and Egr-2 are treated
as a composite species labeled Egr.
(B) Simulations of enforced expression experiments. PU.1 is induced
to high expression levels at t = 60, and C/EBPa is induced at t = 120.
(C) Diagram showing the boundary between themonostable and bista-
ble regimes as a function of the rates of synthesis of PU.1 and C/EBPa.
Perpendicular arrows correspond to the inductive events shown in (B).
Diagonal arrow represents a coordinate increase in both PU.1 and
C/EBPa synthesis, resulting in stochastic cell fate determination
upon entering the bistable region.762 Cell 126, 755–766, August 25, 2006 ª2006 Elsevier Inc.observed when the rates of synthesis of both primary de-
terminants are low (0% t < 60 in Figure 6B). In this case,
the cross-antagonism between Egr and Gfi-1 is weak. Be-
cause each of these factors cannot fully repress the other,
imbalances in their expression levels cannot be main-
tained, and there is only a single possible long-time out-
come (the system is ‘‘monostable’’).
Inducing PU.1 prior to C/EBPa, as in PUERhi cells (60%
t < 120 in Figure 6B), shifts the pattern of gene expression
to that of a macrophage. At t = 120, the rate of C/EBPa
synthesis is also increased, but, due to the imbalance of
the secondary determinants already established, the cell
remains amacrophage. If instead C/EBPa is induced prior
to PU.1, a pattern of gene expression that corresponds
to a neutrophil results (Figure S5), which is in agreement
with earlier work (Dahl et al., 2003). Because the cross-
antagonism between Egr and Gfi-1 is strong when PU.1
and C/EBPa expression levels are high, one secondary
determinant can fully repress the other. As a result, imbal-
ances between Egr and Gfi-1 are self-reinforcing in this
case, and mixed patterns of gene expression are unsta-
ble. The two possible long-time patterns of gene expres-
sion that are robust to perturbations correspond to the
differentiated states (the system is ‘‘bistable’’).
The different behaviors illustrated in Figure 6B are
placed in a broader context in Figure 6C, which shows
the number of stable states of the network as a function
of the rates of synthesis of the primary determinants. As
indicated by the perpendicular arrows, induction of PU.1
at t = 60 promotes a macrophage-like fate, but cells re-
main in the monostable region of parameter space. Sub-
sequently increasing the other factor (C/EBPa) moves
cells into the bistable region, and the resulting switch-
like behavior ensures that they remain committed to their
differentiated state even when the primary factor that di-
rects the alternate fate is induced. This behavior mirrors
the experiments described above and corresponds to an
instructive pathway for specification.
Along the diagonal arrow in Figure 6C, the levels of both
the primary and secondary determinants are comparable
when themixed lineage transitions from stable to unstable
at the boundary between the colored and gray regions
(see Supplemental Data for a quantitative discussion
based on an analytically tractable model). Small cell-to-
cell variations in the relative amounts of the secondary de-
terminants, Egr and Gfi-1, can then cause the population
to partition into macrophages and neutrophils. Thus, the
model encompasses both instructive as well as stochastic
determination of cell fates.
DISCUSSION
Our analysis reveals that Egr-1 and Egr-2 function redun-
dantly to regulate themacrophage cell fate. They do so not
only by positively regulating the expression of macro-
phage specific genes, but also by repressing the alternate
lineage neutrophil genes. Importantly, Egr-1,2 counter-
act an alternate regulator, Gfi-1, which is required for
neutrophil cell fate determination and repression of mac-
rophage genes. This counter-acting circuit explains the
generation of alternate cell fates (macrophage versus neu-
trophil) from a shared pair of lineage determinants (PU.1
and C/EBPa).
We note that, during hindbrain development, Egr-2 is re-
quired for generation of r3 and r5 rhombomeres (Swiatek
and Gridley, 1993). As with macrophage development,
dual regulatory functions for Egr-2 as a positive regulator
of the r3/r5 gene expression program (Giudicelli et al.,
2001) and as a repressor of the alternate r2/r4 program
(Voiculescu et al., 2001) have been suggested. Previous
reports have demonstrated roles for Gfi-1 in the context
of cell fate determination of secretory intestinal cells
(Shroyer et al., 2005) and inner hair cells (Wallis et al.,
2003). These analyses lead us to propose that Egr-1,2
and Gfi-1, or the related family member Gfi-1b (Duan and
Horwitz, 2003), may represent a conserved counter-regu-
latory switch that functions to resolve mixed lineage gene
expression patterns and thereby regulate cell fate determi-
nation in a variety of developmental contexts. It should be
noted that Egr-1,2 and Gfi-1 were discovered in the con-
text of analyses focusing on control of cell growth and
proliferation (Gilks et al., 1993; Sukhatme et al., 1988).
Therefore, they may also function as a counter-regulatory
switch controlling exit from quiescence (G0) into a prolifer-
ative state. Consistent with this proposal, Gfi-1 has been
implicated in regulating hematopoietic stem cell self-
renewal by restricting proliferation (Hock et al., 2004).
Transcriptional priming of distinct cell fates within amul-
tipotential progenitor likely reflects developmentally spe-
cific alterations of chromatin structure at lineage-specific
loci. Such loci are poised for physiologically relevant levels
of lineage-specific gene expression upon differentiation.
We propose that primary cell fate determinants such as
PU.1 and C/EBPa induce mixed lineage transcriptional
priming by functioning as ‘‘pioneer transcription factors’’
to induce initial alterations of chromatin structure at
lineage-specific target genes (Cirillo et al., 2002). Subse-
quently, secondary cell fate determinants (such as Egr-
1,2) function in concert with their corresponding primary
regulators (such as PU.1) to promote the physiological
levels of transcription of the relevant subset of genes.
We note that transcription of the macrophage c-fms
gene is dependent on both PU.1 and Egr-1,2. Whereas
PU.1 binds to the c-fms promoter, Egr-2 appears to regu-
late c-fms transcription by interacting with a downstream
enhancer element (H. Krysinska and C. Bonifer, personal
communication). Thus, concerted activation of transcrip-
tion between primary and secondary determinants would
enable physiological levels of c-fms expression during
macrophage differentiation. How might Egr-1,2 repress
the transcription of Gfi-1 and neutrophil genes? We pro-
pose that repression is dependent on corepressors such
as Nab-2. Consistent with this idea, dEgr-2, which lacks
the Nab-2 interaction domain, fails to repress Gfi-1
(Figure 4C). Furthermore, Nab-2 is required along with
Egr-2 to repress the Gfi-1 promoter (Figure 3C). We positthat Nab-2 is stably associated with Egr-1,2 on repressed,
but not activated, target genes and that such molecular
discrimination is dictated by the context of the cis-
regulatory elements within which Egr binding sites are
embedded.
We note that our regulatory framework of primary and
secondary cell fate determinants applies to several cell
fate choices in the hematopoietic system. In particular,
during B cell development, the transcription factors E2A
and EBF appear to function as primary cell fate determi-
nants (Busslinger, 2004; Singh et al., 2005). The transcrip-
tion factor Pax-5 represents a secondary cell fate deter-
minant analogous to Egr-1,2 and Gfi-1. Its expression is
dependent on EBF and it functions to positively regulate
B lineage genes and to repress myeloid genes. In the con-
text of B lymphoid versus myeloid cell fate choice, Pax-5
activity appears to be counteracted by C/EBPa; the latter
can reprogramB cells into macrophages, in part by antag-
onizing Pax-5 (Xie et al., 2004). In this regard, it is intriguing
that C/EBPa reprograms B cells into macrophages rather
than neutrophils. B cells express Egr-1,2, Nab-2, and low
levels of PU.1 (data not shown). Addition of lymphoid
determinants to our mathematical model predicts that
C/EBPa is unable to induce Gfi-1, as the bistable switch
discussed in the present study is thrown to the macro-
phage-promoting side by the presence of PU.1, Egr-1,2
and Nab-2 (A.W., H.S. and A.R.D., unpublished data).
Finally, in the case of erythrocytic versus megakaryocytic
cell fate choice, GATA-1 represents a shared primary de-
terminant (Cantor and Orkin, 2002; Orkin et al., 1998),
whereas EKLF and Fli-1 may function as a counter-acting
circuit to stabilize one or the other cell fate (Starck et al.,
2003).
Our model reveals general features of transcriptional
networks that may regulate cell fate decisions in diverse
cellular patterning events, including those associated
with embryonic development (Stathopoulos and Levine,
2005). Low levels of a combination of lineage-determining
transcription factors could be generally used to activate a
mixed lineage pattern of gene expression. Such transcrip-
tional priming would represent an obligatory transitional
state, manifested bymultipotential progenitors. Cross-an-
tagonism among secondary cell fate determinants is likely
to be a key feature of gene regulatory networks; it can be
used to refine mixed lineage transcription patterns mani-
fested by multipotential progenitors, thereby ensuring
proper cell fate specification and stabilization. An out-
standing question is how cells like natural killer T cells
modulate the elements of their gene regulatory network
to support stable mixed patterns of gene expression at
physiologic levels (Godfrey et al., 2000).
It is well known that cross-antagonism can give rise to
switch-like behavior (Angeli et al., 2004; Gardner et al.,
2000; Ozbudak et al., 2004). That such a network architec-
ture supports graded responses to stimuli as well is less
appreciated (Ozbudak et al., 2004). Although both types
of behaviors have been elicited synthetically by manipula-
tion of biological circuits (Acar et al., 2005; Biggar andCell 126, 755–766, August 25, 2006 ª2006 Elsevier Inc. 763
Crabtree, 2001; Ozbudak et al., 2004), to the best of our
knowledge, our study is the first to identify a regulatory
network in which naturally arising changes in the number
of stable states regulate patterns of gene expression.
The mathematical model resolves a seeming paradox
concerning myeloid cell development. Counterintuitively,
expression levels of PU.1 andC/EBPa increasewhen cells
differentiate, and there are binding sites for both these
factors on the downstream macrophage and neutrophil
genes. Expressing both primary determinants at high
levels disfavors mixed patterns of gene expression be-
cause the secondary cross-antagonism is sufficiently
strong to make imbalances in Egr-1,2/Nab-2 and Gfi-1
self-reinforcing. The resulting bistability then serves to
lock the cell into one of two well-defined differentiated
states, both of which are robust to further changes in the
primary determinants. The inducible switch-like nature of
the cross-antagonism identified here is thus likely to play
an important role in lineage commitment even in instruc-
tive situations, such as that considered in Figure 6B.
We note that the bistable state could also be exploited
during the course of cell fate specification. We see in Fig-
ure 6C that coordinately increasing the synthesis of both
primary cell fate determinants causes cells to transition
into the bistable region with comparable levels of the
secondary determinants. Amplification of imbalances in
Egr-1,2/Nab-2 and Gfi-1 through the self-reinforcingmech-
anism described above could then allow cell-to-cell va-
riation to determine cell fates. This stochastic pathway
obviates the need for generating separate instructive
cues in the same compartment. In the hematopoietic sys-
tem there is evidence for this model, particularly with re-
gard to the development of erythroid and myeloid cell
types (Enver et al., 1998; Metcalf, 1998).
EXPERIMENTAL PROCEDURES
Isolation and Culture of Cells
Isolation of primary cells is detailed in the Supplemental Data. Formac-
rophage development, hematopoietic progenitors were cultured in
IMDM with 10 ng/ml M-CSF for 4 days. For clonogenic assays, hema-
topoietic progenitors were cultured in Methocult 3424 supplemented
with 1 ng/ml GM-CSF or 10 ng/ml M-CSF (DeKoter et al., 1998). For
experiments involving serum starvation, NIH3T3 cells were plated in
media containing 0.15% FCS overnight and subsequently restimu-
lated with 20% FCS for 1.5 hr.
Establishment and Analysis of IL-3-Dependent
PU.1/ Cell Lines
Generation of PUERhi cells has been described previously (Walsh
et al., 2002). The PUERlo cells were generated by infection of a
PU.1/ IL-3-dependent line with a bicistronic retrovirus encoding
PUER and GFP. After infection, cells were FACS sorted for low levels
of GFP expression and subsequently cloned by limiting dilution.
PU.1/ cell lines were cultured in IL-3 (5 ng/ml) except where noted
for G-CSF (10 ng/ml). Differentiation of PUER cells was induced by cul-
ture in the presence of OHT (100 nM) and analyzed by cytochemical
staining and flow cytometry (Dahl et al., 2003; Walsh et al., 2002). Total
RNA was isolated using RNAzol (Tel-Test, Inc.) and expression of var-
ious genes was analyzed by RT-PCR or Q-PCR after normalization
with hprt. Sequences of PCR primers are available upon request.764 Cell 126, 755–766, August 25, 2006 ª2006 Elsevier Inc.Immunoblots were performed as previously described (DeKoter
et al., 1998) and details are available in the Supplemental Data.
Mice
Timed matings between Egr mutant mice (Lee et al., 1996; Swiatek
andGridley, 1993)were performed (Egr-2+/3Egr-2+/orEgr-1/3
Egr-1+/) and embryos obtained at day 14.5 gestation. Egr-1 or Egr-2
mutant embryos were identified by genotyping. Primer sequences are
available upon request. Egr-1/Egr-2+/ compoundmice were gener-
ated by Egr-1/Egr-2+/ orEgr-1+/Egr-2+/ (male)3 Egr-1+/Egr-2+/
(female) matings.
Single-Cell RT-PCR
Multiplex single-cell RT-PCR was performed as previously described
(Hu et al., 1997). Details are available in the Supplemental Data.
Microarray Analysis
Biotin labeled cRNA was generated and hybridized to the Mouse Ge-
nome 430 2.0 Array according to manufacturer’s instructions (Affyme-
trix). Details are available in Supplemental Data.
Construction and Use of Small Hairpin Interfering RNA Plasmids
Plasmids encoding shRNA oligonucleotides were constructed as de-
scribed by Hannon et al. (http://katahdin.cshl.org/; Gregory Hannon
Lab under the Labs option on the navigation bar). Details are available
in Supplemental Data.
Complementation of shEgr-2 Cells
Mig-mEgr-1 andMig-huEgr-2 were generated by cloningmurine Egr-1
and human Egr-2 cDNA fragments into the Mig-R1 vector (DeKoter
et al., 2002). Complementation of shEgr-2 cells was performed by
electroporation using linear Mig-R1, Mig-mEgr-1, or Mig-huEgr-2
DNA. After 48 hr, GFP-expressing cells were isolated by FACS sorting.
Cells were expanded for 7 to 10 days and subsequently differentiated
in the presence of OHT (100 nM).
Chromatin Immunoprecipitation Assays
Chromatin cross-linking and immunoprecipitation assays were per-
formed as previously described (DeKoter et al., 2002). Details are avail-
able in Supplemental Data.
Retroviral Transduction
Retroviral transfection of PUERhi or NIH3T3 cells was performed by
spin infection (Dahl et al., 2003) using Mig-Gfi-1 or Mig-dEgr-2 retrovi-
ral supernatants. After 2 days, GFP+ cells were sorted and propagated.
Transient Transfections and Reporter Assays
The proximal promoters of murine Egr-2 (650 to +100) and Gfi-1
(500 to +150) genes were cloned into the pGL3-basic vector (Prom-
ega). AnEgr binding sitewas identifiedwithin themouseGfi-1promoter
region (CAGTGGGCG; position –176) using TRANSFAC (http://
www.gene-regulation.com/). Mutation of the Egr site (CAGTcGGCG)
within theGfi-1promoterwasperformedby site-directedmutagenesis.
Reporter assays were performed using NIH3T3 cells as previously
described (Russo et al., 1995). Details are available in theSupplemental
Data.
Mathematical Modeling of Gene Regulatory Network
The model for gene expression and its analysis are similar in form to
earlier such treatments (Acar et al., 2005; Elowitz and Leibler, 2000;
Gardner et al., 2000; Ozbudak et al., 2004) and are described in the
Supplemental Data.
Supplemental Data
The Supplemental Data for this article can be found online at http://
www.cell.com/cgi/content/full/126/4/755/DC1/.
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